News
PANTHERx® Rare Pharmacy, a leader in rare disease product patient access and support services in the United States, announced ...
With a landmark U.S. approval Tuesday, Insmed is making waves with a new class of drug that’s also the first to be green lit ...
1d
Investor's Business Daily on MSNTop 5% Biotech, Insmed, Hits A Record High On Its 'Skeleton Key' Approval
InsmedINSM stock hit a record high Tuesday after the Food and Drug Administration approved its drug, brensocatib, for ...
Q2 2025 Management View William H. Lewis, President, CEO & Chairman, highlighted, "Insmed is now three for three, all three ...
Arguably the FDA’s most anticipated decision this month is for a subcutaneous induction formulation of Biogen and Eisai’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results